Blood Storage Related Mortality and Adverse Effects in Trauma Patients

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-75
SponsorKocaeli City Hospital

About this trial

The purpose of this retrospective study is to examine the following factors related to blood storage time in severely injured trauma patients who received large blood transfusions:

1. The effect of blood storage time on the patient's 28-day mortality rate. 2. The relationship between storage time and other health problems that the patient may develop (such as heart disease, vascular occlusion, respiratory failure, infection, and organ failure).

For this purpose, patients aged 18-75 who were admitted directly from the scene of injury and received large transfusions at Jacksonville Shands Hospital between January 1, 2023, and October 1, 2025, will be included. Data will be obtained from hospital information systems and anesthesia records

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Patients between 18-75 years of age,

Injury Severity Score>15 and have received massive blood transfusions in our hospital from 1 January 2015 to 31 December 2025

The patients admitted because of trauma and undergoing surgery

Disqualifiers

Patients with known cardiac or vascular diseases such as heart failure or malignant hypertension, those under anticoagulant treatment

Patients with known serious kidney (on dialysis), lung, liver diseases, those under anticoagulant treatment

Super obese patients with body mass index (BMI) 50 or above

Trial population

In our study, patients between the ages of 18-75, directly from the scene of injury, ISS\>15 and who received massive blood transfusion (\>10 packed RBC units in the first 24 hours, with an alternative definition of greater than or equal to 3 packed RBC units transfused in 1 hour) will be included in the study at University of Florida Jacksonville Shands Hospital between the dates 1 January 2023 to 1 31 December 2025.

Trial design

Design model

Cohort

Time perspective

Retrospective

Treatments tested in this trial

Not listed

Trial groups

300 Participants
are grouped into 1 trial group
Group A: Group 1

Trial outcomes

Primary outcomes

1

28-day Mortality

The aim of this study was to evaluate the effect of red blood cell and whole blood storage duration on 28-day mortality in severely injured trauma patients (injury severity score \>15) undergoing massive transfusion.

Time frame
At the day of 28 after massive blood transfusion

Secondary outcomes

1

28-day Morbidity - Cardiac Ischemia

On the 28th day after the blood transfusion, patients will be assessed for cardiac ischemia.

Time frame
At the day of 28 after massive blood transfusion
2

28-day morbidity- thromboembolic events

On the 28th day after the blood transfusion, patients will be assessed for thromboembolic events,

Time frame
At the day of 28 after massive blood transfusion
3

28-day morbidity- nosocomial infection

On the 28th day after the blood transfusion, patients will be assessed for nosocomial infection,

Time frame
At the day of 28 after massive blood transfusion
4

28-day morbidity- multiple organ failure

On the 28th day after the blood transfusion, patients will be assessed for multiple organ failure.

Time frame
At the day of 28 after massive blood transfusion

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.